Statin therapy and association with ovarian cancer risk in the New England Case Control (NEC) study

International Journal of Cancer. Journal International Du Cancer
Babatunde AkinwunmiDaniel W Cramer

Abstract

Statins are widely used to lower blood cholesterol and reduce risk for cardiovascular diseases, but attention has recently focused on a role in cancer prevention or therapy. Here we present data from a large case-control study addressing whether statin use can lower the risk for epithelial ovarian cancer (EOC). Between 1992 and 2008, data including medications used for at least 6 months were collected from 2,040 cases with EOC and 2,100 frequency-matched controls without the disease who participated in the New England Case Control study. We used unconditional logistic regression controlling for matching factors and potential confounders to examine the association between statin use and the risk for EOC. Overall, women who used statins had 32% lower risk of ovarian cancer compared to non-users (Odds ratio (OR) 0.68, 95% Confidence Interval (CI): 0.54-0.85), adjusting for the matching factors and other covariates. The reduced risk was most apparent in women taking a lipophilic statin who began use after age 49, and who had used them 2-4.9 years. Statin use was associated with lower risks for both serous and non-serous histologic subtypes with the strongest effect seen for mucinous and mixed epithelial subtypes. The association be...Continue Reading

References

Jan 1, 1992·Annual Review of Nutrition·S B Kritchevsky, D Kritchevsky
Jan 3, 1996·Journal of the National Cancer Institute·K J HelzlsouerG W Comstock
Jan 12, 1999·American Journal of Epidemiology·L H KushiT A Sellers
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthijs R GraafHenk-Jan Guchelaar
Dec 27, 2005·Current Cancer Drug Targets·Józef Dulak, Alicja Józkowicz
Jan 5, 2006·JAMA : the Journal of the American Medical Association·Krista M DaleC Michael White
Feb 21, 2006·Cancer Causes & Control : CCC·Jeanine M GenkingerStephanie A Smith-Warner
Nov 30, 2006·International Journal of Cancer. Journal International Du Cancer·Danielle R L Browning, Richard M Martin
Jun 19, 2007·Bioorganic & Medicinal Chemistry Letters·Jeffrey A PfefferkornMatthias Eberstadt
Jun 13, 2008·International Journal of Cancer. Journal International Du Cancer·Hang Xiao, Chung S Yang
Dec 2, 2008·Cancer Causes & Control : CCC·Onchee YuDiana L Miglioretti
Apr 10, 2010·Expert Opinion on Drug Safety·Denise M BoudreauJeanene Johnson
Apr 8, 2011·Obstetrics and Gynecology·Allison F VitonisDaniel W Cramer
May 28, 2011·The Lancet Oncology·Linda E Kelemen, Martin Köbel
Aug 5, 2011·Journal of the National Cancer Institute·Thomas P AhernTimothy L Lash
May 18, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer C MelvinMieke Van Hemelrijck
Jan 30, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Siddharth SinghPrasad G Iyer
Mar 5, 2013·Cancer Causes & Control : CCC·Mette T FaberUNKNOWN Ovarian Cancer Association Consortium
Apr 20, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P P Singh, S Singh
May 31, 2013·Gynecologic Oncology·Ofer LavieGad Rennert
Oct 2, 2013·Nature Reviews. Clinical Oncology·Naomi Gronich, Gad Rennert
Feb 22, 2014·Gynecologic Oncology·Gad RennertOfer Lavie
May 14, 2014·Annals of Family Medicine·Michael Edward JohansenCaroline R Richardson
Nov 14, 2014·British Journal of Cancer·L BaandrupS K Kjær
Mar 15, 2015·Journal of the National Cancer Institute·Michael HoffmeisterHermann Brenner
Jun 17, 2015·Gynecologic Oncology·Victoria SopikSteven A Narod
Jul 23, 2015·Journal of Gynecologic Oncology·Muhammad Shahzeb Khan Rameez
Feb 26, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ashwin N AnanthakrishnanIsaac Kohane
May 14, 2016·International Journal of Cancer. Journal International Du Cancer·Sashidhar ManthravadiSheshadri Madhusudhana
May 21, 2016·Scientific Reports·Guo-Chao ZhongJian-Ping Gong
Jul 1, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P P Singh, S Singh

❮ Previous
Next ❯

Citations

Sep 13, 2019·Menopause : the Journal of the North American Menopause Society·Stephanie S FaubionVirginia M Miller
May 3, 2019·Endocrine-related Cancer·Sisi HeErik R Nelson
Oct 24, 2020·International Journal of Molecular Sciences·Mariana NunesSara Ricardo
Jan 30, 2021·European Journal of Pharmacology·Natalia Manzano-León, Patricia Garcia-Lopez
Feb 15, 2021·Current Oncology Reports·Nalinie Joharatnam-HoganRuth E Langley
Mar 23, 2021·Translational Oncology·Shyamananda Singh MayengbamManoj Kumar Bhat
Jun 15, 2019·Cell Calcium·Sana KoubaMarie Potier-Cartereau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.